GPX4 and glioblastoma: Extensive research has been undertaken to evaluate the anticancer properties of various potential therapeutic agents, with particular attention to their effects on critical signalling pathways such as cell cycle regulation, migration/invasion, apoptosis, ferritinophagy, and the HSPA5/NRF2/GPx4/GSH axis in glioblastomas [24, 25, 27, 28, 29].